

HY-151436 · 50 mg
MedChemExpress · Cat: HY-151436
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/zlmt-12.html
Description
ZLMT-12 compound 35 , tacrine derivatives, is a potent, orally active CDK2/9 inhibitor with IC50 values of 0.002 and 0.011 ?M for CDK9 and CDK2, respectively. ZLMT-12 has a weak inhibitory effect on AChE IC50=19.023 ?M and BChE IC50=2.768 ?M . ZLMT-12 has low toxicity and antiproliferative activity. ZLMT-12 induces apoptosis and arrests the cell cycle in the S phase and G2/M phase.







